TheNote.app
JAMA – The Latest Medical Research, Reviews, and Guidelines

Active Monitoring for Low-Risk Ductal Carcinoma In Situ

To the Editor The COMET trial compared active monitoring with guideline-concordant care in patients with low-risk ductal carcinoma in situ (DCIS).
favicon
jamanetwork.com
jamanetwork.com
RSS Hunter
© 2015-2025, TheNote.app
· Privacy Policy · Terms & Conditions · Contact · Android iOS MacOS